Main menu

NEW YORK (GenomeWeb News) – The Leukemia and Lymphoma Society has awarded a $6.3 million grant for research at the University of Cambridge that will use genome-wide analysis to study drug responses used for blood cancer treatment, LLS said Monday.

The grant, which provides $1.25 million per year for five years, was funded under the LLS Marshall A. Lichtman Specialized Center of Research (SCOR) grant program.